With effect from 2015 all the annual financial statements of the Leriva companies are prepared in accordance with the Greek Accounting Standards (Law 4308/2014) which incorporates the provisions of European Directive 2013/34/EU on annual financial statements. For prior years the annual financial statements of the Group’s companies were prepared under Greek GAAP ("GAAP") and the accounting provisions of Law 2190/1920.
Financial Highlights
Consolidated sales for the fiscal year ended December 31, 2025, amounted to €24,280,795, representing an 8.2% increase over € 22,432,985 in 2024. Consolidated net income for 2025 totaled € 2,189,816, or 9% of sales, against 1,058,951, or 4.7% of sales, recorded in the prior year. The Group employed 75 individuals as at the end of 2025, a slight contraction from 78 individuals as at the end of 2024.
The annual financial statements of each of the Leriva legal entities can be accessed by clicking on the links below.
Leriva Holdings SA
Leriva SA
Leriva Diagnostics SA
Leriva Pharma SA (formerly Leriva Imaging SA)




